Pregnancy after adolescent and adult cancer: A population-based matched cohort study
Corresponding Author
Hanne Stensheim
Department of Clinical and Registry-based Research, Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
Tel.: +47 22451300, Fax: +47 22451370
Cancer Registry of Norway, PO Box 5313 Majorstuen, N-0304 Oslo, NorwaySearch for more papers by this authorMilada Cvancarova
Department of Clinical and Registry-based Research, Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
Department of Oncology, National Resource Center for Late Effects, Oslo University Hospital and University of Oslo, Norway
Search for more papers by this authorBjørn Møller
Department of Clinical and Registry-based Research, Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
Search for more papers by this authorSophie D. Fosså
Department of Oncology, National Resource Center for Late Effects, Oslo University Hospital and University of Oslo, Norway
Search for more papers by this authorCorresponding Author
Hanne Stensheim
Department of Clinical and Registry-based Research, Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
Tel.: +47 22451300, Fax: +47 22451370
Cancer Registry of Norway, PO Box 5313 Majorstuen, N-0304 Oslo, NorwaySearch for more papers by this authorMilada Cvancarova
Department of Clinical and Registry-based Research, Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
Department of Oncology, National Resource Center for Late Effects, Oslo University Hospital and University of Oslo, Norway
Search for more papers by this authorBjørn Møller
Department of Clinical and Registry-based Research, Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway
Search for more papers by this authorSophie D. Fosså
Department of Oncology, National Resource Center for Late Effects, Oslo University Hospital and University of Oslo, Norway
Search for more papers by this authorAbstract
Despite fertility-preserving initiatives, postcancer reproduction is expected to be lower than that of the general population. Using data from the Cancer Registry and the Medical Birth Registry of Norway, postcancer pregnancy rates were analyzed in 27,556 survivors and compared to those from a matched comparison group (“controls”) from the general population. All were born after 1950, diagnosed from 1967 to 2004 at age of 16–45, and had an observation time from the date of diagnosis (assigned date for controls), until pregnancy, death, age 46, or December 31, 2006. Cox regression was used to estimate pregnancy rates, after adjusting for educational level, parity and diagnostic period. Overall, cancer survivors had a lower pregnancy rate than the controls, but the rate for survivors was higher in males than in females [hazard rate (HR) = 0.74 (95% confidence interval (CI) 0.71–0.78) and HR = 0.61 (95% CI 0.58–0.64), respectively]. However, the rates did not differ between controls and survivors of malignant melanoma or thyroid cancer. By contrast, the lowest HRs for pregnancy occurred in survivors of leukemia, cervical or breast cancer. Increased pregnancy rates during the study period were detected for ovarian cancer [HR = 0.2 (95% CI 0.1–0.3) to HR = 0.7 (95% CI 0.5–0.9)], testicular cancer [HR = 0.6 (95% CI 0.4–0.9) to HR = 0.8 (95% CI 0.7–0.8)], and Hodgkin lymphoma diagnosed in men [HR = 0.7 (95% CI 0.5–0.9) to HR = 0.9 (95% CI 0.7–1.0)]. In summary, fertility-preserving attempts have succeeded in patients with ovarian or testicular cancer and in males with Hodgkin lymphoma. Male survivors initiated pregnancies in a higher degree than female survivors.
Supporting Information
Additional Supporting Information may be found in the online version of this article.
Filename | Description |
---|---|
IJC_26045_sm_SuppTable1.doc81 KB | Supporting Information Table 1. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1 Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917–31.
- 2 Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 ( Suppl 5): v266–73.
- 3 Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 1985; 21: 601–5.
- 4 Kiserud CE, Fossa A, Holte H, Fossa SD. Post-treatment parenthood in Hodgkin's lymphoma survivors. Br J Cancer 2007; 96: 1442–9.
- 5 Brydoy M, Fossa SD, Dahl O, Bjoro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol 2007; 46: 480–9.
- 6 Makar AP, Trope C. Fertility preservation in gynecologic cancer. Acta Obstet Gynecol Scand 2001; 80: 794–802.
- 7
Dargent D,
Martin X,
Sacchetoni A,
Mathevet P.
Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients.
Cancer
2000;
88:
1877–82.
10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.0.CO;2-W CAS PubMed Web of Science® Google Scholar
- 8 Cvancarova M, Samuelsen SO, Magelssen H, Fossa SD. Reproduction rates after cancer treatment: experience from the Norwegian Radium Hospital. J Clin Oncol 2009; 27: 334–43.
- 9 Magelssen H, Melve KK, Skjaerven R, Fossa SD. Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod 2008; 23: 178–86.
- 10 Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ 2007; 334: 194.
- 11 Kroman N, Jensen MB, Wohlfahrt J, Ejlertsen B. Pregnancy after treatment of breast cancer—a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol 2008; 47: 545–9.
- 12 Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002; 20: 1880–9.
- 13 Brydoy M, Fossa SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97: 1580–8.
- 14 Madanat LM, Malila N, Dyba T, Hakulinen T, Sankila R, Boice JD, Jr., Lahteenmaki PM. Probability of parenthood after early onset cancer: a population-based study. Int J Cancer 2008; 123: 2891–8.
- 15 Syse A, Kravdal O, Tretli S. Parenthood after cancer—a population-based study. Psychooncology 2007; 16: 920–7.
- 16 Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Moller B. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218–31.
- 17 Cancer Registry of Norway. Cancer in Norway 2005. Oslo: Cancer Registry of Norway, 2006.
- 18 Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study. J Clin Oncol 2009; 27: 45–51.
- 19Registries and Statistics: The Medical Birth Registry. 2010. Available from: http://www.fhi.no.
- 20Statistics Norway. 2010. Available from: http://www ssb no.
- 21 Nissen-Meyer R, Høst H, Kjellgren K, Månsson B, Norin T. Neoadjuvant chemotherapy in breast cancer: as single perioperative treatment and with supplementary long-term chemotherapy. In: SE Salmon, ed. Adjuvant therapy of cancer. Philadelphia: WB Saunders, 1987. 253–61.
- 22 Raabe NK, Kaaresen R, Fossa SD. Analysis of adjuvant treatment in postmenopausal patients with stage II invasive breast carcinoma—a pattern of care study and quality assurance of 431 consecutive patients in Oslo 1980–1989. Acta Oncol 1997; 36: 255–60.
- 23 Kolstad P. Clinical gyneocologic oncology: the Norwegian experience. Oslo: Norwegian University Press, 1986.
- 24 Gershenson DM. Management of early ovarian-cancer—germ-cell and sex cord-stromal tumors. Gynecol Oncol 1994; 55: S62–S72.
- 25 Fossa SD, Kravdal O. Fertility in Norwegian testicular cancer patients. Br J Cancer 2000; 82: 737–41.
- 26 Oldenburg J, Alfsen GC, Waehre H, Fossa SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer 2006; 94: 820–7.
- 27 Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fossa SD. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 1999; 80: 249–55.
- 28 Evensen SA, Stavem P. New therapeutic programs for adult patients with acute leukemia. Tidsskr Nor Laegeforen 1983; 103: 2028–32.
- 29 Bonadonna G. Chemotherapy of malignant lymphomas. Semin Oncol 1985; 12: 1–14.
- 30 Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009; 170: 244–56.
- 31 Syse A. Does cancer affect marriage rates? J Cancer Surviv 2008; 2: 205–14.
- 32 Rippy EE, Karat IF, Kissin MW. Pregnancy after breast cancer: the importance of active counselling and planning. Breast 2009; 18: 345–50.
- 33 Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fossa SD. Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it? Eur Urol 2005; 48: 779–85.
- 34 Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006; 24: 1045–51.
- 35 Lonning PE. Adjuvant endocrine treatment of early breast cancer. Hematol Oncol Clin North Am 2007; 21: 223–38.
- 36 Swain SM, Jeong JH, Geyer CE, Jr., Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 2010; 362: 2053–65.
- 37 Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Gomez SL, Miles S, Neugut AI. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 2010; 28: 4120–8.
- 38 Huyghe E, Matsuda T, Daudin M, Chevreau C, Bachaud JM, Plante P, Bujan L, Thonneau P. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 2004; 100: 732–7.
- 39 Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, Newton Bishop JA. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 2004; 22: 4369–75.
- 40 Fossa SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R. Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report. J Natl Cancer Inst Monogr 2005; 77–82.
- 41 Sawka AM, Lakra DC, Lea J, Alshehri B, Tsang RW, Brierley JD, Straus S, Thabane L, Gafni A, Ezzat S, George SR, Goldstein DP. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf) 2008; 69: 479–90.
- 42 Sawka AM, Lea J, Alshehri B, Straus S, Tsang RW, Brierley JD, Thabane L, Rotstein L, Gafni A, Ezzat S, Goldstein DP. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol (Oxf) 2008; 68: 610–7.
- 43 Hall JE, Martin KA, Whitney HA, Landy H, Crowley WF, Jr. Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumors. J Clin Endocrinol Metab 1994; 79: 1166–72.
- 44 Darzy KH, Shalet SM. Hypopituitarism following radiotherapy. Pituitary 2009; 12: 40–50.
- 45 Elis A, Tevet A, Yerushalmi R, Blickstein D, Bairy O, Dann EJ, Blumenfeld Z, Abraham A, Manor Y, Shpilberg O, Lishner M. Fertility status among women treated for aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 2006; 47: 623–7.
- 46 Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045–52.
- 47 Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010; 116: 2908–14.
- 48 Kawamura S, Suzuki Y, Tamai Y, Itoh J, Fukushima K, Takami H, Yoshida Y, Sawada Y, Sakata Y. Pregnancy outcome among long-term survivors with acute leukemia. Int J Hematol 1995; 62: 157–61.